Podcast: The Future Of Legal Services Featuring Neil Miller

By | Artificial Intelligence, Current Affairs, Entrepreneurs, Knowledge, Partner Insight, Podcasts

The future of legal services with Legit Patents and JAG Shaw Baker by This Much I Know What does the advent of artificial intelligence spell for the future of legal services and lawyers themselves? On that topic Seedcamp partner Carlos Espinal is joined by founder and CEO Matt Osman of Legit Patents, the startup building AI-powered applications to automate parts of the R&D process, and Neil Miller, Partner at JAG Shaw Baker and formerly General Counsel at SoundCloud. Our Partner, Neil Miller joined a recent Seedcamp podcast hosted by Carlos Espinal to talk about the future of legal services. Neil…

Read More

Atomico Leads $30 M Investment Round in AI Chip Company Graphcore

By | Artificial Intelligence, Client news, investors, Knowledge, Partner Insight, Robots

Artificial intelligence (AI) takes another step forward. Graphcore, a UK chip designer that designs chips specifically for AI, recently closed a $30 M round to support their continued expansion. The round was led by our client, Atomico and included existing investors Amadeus Capital, Robert Bosch Ventures Captial, C4 Ventures, Dell Technologies Capital, Draper Esprit Plc, Foundation Capital, Pitango and Samsung Catalyst Fund. Atomico is a London-based venture capital firm founded by Niklas Zennstrom, a co-founder of Skype. AI Everywhere According to a recent Bloomberg article, the investors in the round also included several machine learning experts such as Demis Hassabis, the co-founder and CEO of DeepMind. Owned by Alphabet Inc., DeepMind is an…

Read More

European Commission Looks At EU-Wide Civil Law Rules On Robotics And Artificial Intelligence

By | Artificial Intelligence, Current Affairs, Data & Privacy, European Commission, Intellectual Property, Knowledge, Robots

EU told to lead the way on liability rules and ethical standards for Artificial Intelligence. The  European Commission delivers its initial response. In our blog last month, we looked at the Member of the European Parliaments’ (MEPs’) request for the European Commission to lead the way on developing EU-wide liability rules and ethical standards to deal with artificial intelligence. The EU Commission has now issued a response which identifies the need for legal certainty and the legal challenges it faces in identifying where liability should fall amongst the different market players. EU Commission response on liability  The EU Commission wants to capitalise on…

Read More

Liability Rules And Ethical Standards For Artificial Intelligence

By | Artificial Intelligence, Current Affairs, Data & Privacy, Intellectual Property

EU told to lead the way on liability rules and ethical standards for Artificial Intelligence  Artificial Intelligence (AI) is constantly evolving and continues to roll into all facets of industry – from neural networks that connect recycling systems to sort recycling better to AI that makes self-driving cars safer or teaches machines to do more with less. As AI becomes more commercialised, it reveals the complexities around allocating risk and liability for the autonomous actions of AI. Existing EU laws governing liability are largely stable where human input is prevalent in the machine-decision making process. Consider a human instructing Siri…

Read More

How To Commercialise Life Sciences: Focus On The Basics

By | Biotech, Current Affairs, Guest Posts, Knowledge, Life Sciences

Life sciences research can translate into solutions, products and companies that provide significant benefit to both society and the economy. Today’s dynamic ecosystem presents tremendous opportunities for life sciences innovators given technological advances and rapidly changing market realities. Although the environment for commercialisation has changed dramatically over the last few decades, the basic principles of making it a success remain the same. A commercialisation plan enables innovators to set out and communicate their strategy to others. It should offer a clear and concise overview of the technology’s market potential and the planned route to commercialisation. It should also illustrate how…

Read More

The Power Of The Crowd At Millennial 20/20

By | Entrepreneurs, Events

Earlier this month, the Truman Old Brewery in East London was host to Millennial 20/20, a two day summit that looks at how companies of all scales are adapting to ensure ongoing engagement with the ever-changing consumer. JAG Shaw Baker Associates, Charlotte Courtney and Imran Bhatia, joined delegates from a of variety of sectors from fashion and beauty to finance, travel and food, each bringing a different perspective on how millennials are disrupting their businesses. The Power of the Crowd Day one included a session on the power of the crowd to shape the finance sector. Crowdfunding is demanding increasing levels of attention from companies looking to…

Read More

Elasmogen Inks Research Agreement To Develop New Class Of Therapeutics

By | Biotech, Client news, Knowledge, Life Sciences, Startups

Congratulations to our client Elasmogen! Elasmogen, a spin-out from Aberdeen University, alongside Canada based Feldan Therapeutics, have announced a research agreement with Amgen to develop and deliver novel intracellular biologics. The collaboration combines the unique capabilities of Feldan’s Shuttle platform and Elasmogen’s soloMER™ technology to develop the delivery system and binding domains for two undisclosed intracellular targets for Amgen. Elasmogen develops new medicines based on antibody-like molecules isolated from sharks, called VNARs (variable new-antigen receptors). VNARs are found in sharks as part of their immune system and have a similar protective role to antibodies present in the human body. The…

Read More

The Ins and Outs of Clinical Trials – Termination

By | Biotech, Knowledge, Life Sciences

Clinical trials are costly, involve numerous parties and depending on the phase of the trial, are a lengthy process. Although it’s unpleasant to talk about how to end a relationship before it’s even begun, a frank and complete discussion at the outset on how a contract is to be terminated amicably will benefit all parties involved. In this post, we’ll address a termination provision that a sponsor, typically a pharmaceutical company, can exercise and negotiate. Such provision is particular to a clinical trial agreement and which can be challenging to negotiate with other parties to the agreement, i.e. the institution…

Read More

Fake News And Its Impact On Tech Companies

By | Current Affairs, Data & Privacy, Fake News, Knowledge, Safe Harbours

Recently, there have been rising concerns that the public is being deceived by the unprecedented dissemination of fake news on the internet and on social media, in particular. The term fake news is a fluid concept but is generally understood to refer to fictitious reports designed to deliberately deceive readers in order to maximise internet traffic and profit. The term gained particular traction during the 2016 US presidential election following claims of harm to democratic process. Some people are taking the fight against fake news on themselves. The Fake News Challenge is a global grassroots effort of more than 100…

Read More

MyBuilder Acquired by HomeAdivsor

By | Client news, Current Affairs, Entrepreneurs, Investor and VC News, M&A, Startups

We ended March on a high note with some great M&A news for our client MyBuilder. The UK company was recently acquired by HomeAdvisor, an IAC company (NASDAQ: IAC) considered one of the largest home marketplaces in the world. JAG Shaw Baker represented the interests of MyBuilder and its investors, including the founder. This deal is a great example of JAG Shaw Baker’s expertise in creating the right balance between the interests of the selling parties to generate a sensible sell-side proposition to then deliver the sale to the buyer. The firm is proud to have been a part of this deal which was effectively done in a sharp two week period. According…

Read More

A cookie is a small file of letters and numbers that we store on your browser or computer, phone or tablet hard drive if you agree. more information

INFORMATION ABOUT OUR USE OF COOKIES Our website uses cookies to distinguish you from other users of our website. This helps us to provide you with a good experience and also allows us to improve our website. By continuing to browse the website, you are agreeing to our use of cookies. A cookie is a small file of letters and numbers that we store on your browser or computer, phone or tablet hard drive if you agree. We use the following cookies: • Strictly necessary cookies. These are cookies that are required for the operation of our website. They include, for example, cookies that enable you to return to a previous page. • Analytical/performance cookies. They allow us to recognise and count the number of visitors and to see how visitors move around our website when they are using it. This helps us to improve the way our website works, for example, by ensuring that users are finding what they are looking for easily. The analytical/performance cookies are provided on our behalf by Google Inc. to aid with reporting of user behaviour, market research and improving website functionality. This user behaviour is analysed in order to improve this website. To see how this applies to Google Analytics, visit http://www.google.co.uk/intl/en/analytics/privacyoverview.html. You can stop tracking by Google Analytics by visiting https://tools.google.com/dlpage/gaoptout?hl=en-GB. COOKIE DURATION The strictly necessary session cookies are a temporary cookie which remains in the cookie file of your browser until you close the browser. The other cookies will remain in the cookie file of your browser after the closing of the browser, and will become active again when you reopen this website. The different cookies have different expiration dates. Following expiry of a cookie, a new version of that cookie will be downloaded when you next visit this website, unless you have withdrawn your consent in the meantime. You can block cookies by activating the setting on your browser that allows you to refuse the setting of all or some cookies. However, if you use your browser settings to block all cookies (including essential cookies) you may not be able to access all or parts of our website. Contact If you have any queries regarding this cookie policy please contact us at info@jagshawbaker.com.

Close